₹ 0.18
-0.01 (-5.26%)
BSE
W
Welcure Drugs & Pharmaceuticals
₹ 0.18
BSE
WELCURE Financials Summary
Welcure Drugs & Pharmaceuticals revenue decreased 100.00% quarter-on-quarter to ₹0 Cr in Mar 2026, while net profit swung to a loss of ₹50 Cr from a profit of ₹1 Cr in the previous quarter. Compared to the same quarter last year, revenue is down 100.00% and net profit swung to a loss of ₹50 Cr from a profit of ₹3 Cr a year ago. EPS for the quarter stood at -₹0.40, decreased from ₹0.13 in the previous quarter and down from ₹0.33 a year ago.
Welcure Drugs & Pharmaceuticals Financials
Income Statement
In Cr
Balance Sheet
In Cr
Cash Flow
In Cr
Get In-depth View of WELCURE Quaterly Results, Balance Sheet, Cashflows & Corporate Action.
WELCURE Revenue Growth
All values are in Crores
Revenue
Profit
Loss

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






